SCHOTT Pharma AG & Co. KGaA (ETR:1SXP)
Germany flag Germany · Delayed Price · Currency is EUR
23.00
+0.10 (0.44%)
Last updated: Aug 14, 2025

ETR:1SXP Income Statement

Millions EUR. Fiscal year is Oct - Sep.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jun '25 Sep '24 Sep '23 Sep '22 Sep '21 Sep '20
Revenue
975.68957.09898.6821.14648.67584.23
Revenue Growth (YoY)
2.86%6.51%9.43%26.59%11.03%-
Cost of Revenue
646.59634.48582.11524.51422.5388.22
Gross Profit
329.09322.61316.49296.64226.17196.01
Selling, General & Admin
128.54125.18122.68110.7892.589.63
Research & Development
26.9724.2526.8223.5322.2923.58
Other Operating Expenses
-25.28-15.67-4.23-5.68-3.12-8.18
Operating Expenses
130.22133.77145.28128.63111.67105.04
Operating Income
198.86188.84171.21168.01114.590.97
Interest Expense
-18.2-12.78-6.66-2.11-1.19-1.51
Interest & Investment Income
7.575.965.232.140.560.56
Earnings From Equity Investments
13.5712.4911.7412.9913.75.55
Currency Exchange Gain (Loss)
-11.09-11.092.71-7.03-1.450.45
Other Non Operating Income (Expenses)
-0.33-1.08-4.55-5.54-3.26-1.55
EBT Excluding Unusual Items
190.37182.35179.68168.46122.8794.46
Merger & Restructuring Charges
----11.78--
Gain (Loss) on Sale of Assets
0.590.590.391.510.30.72
Asset Writedown
--5.2---
Pretax Income
192183.97185.8158.29123.2895.3
Income Tax Expense
44.533.6333.8732.4422.1217.67
Earnings From Continuing Operations
147.5150.35151.93125.85101.1777.63
Minority Interest in Earnings
-0.62-0.66-0.09-0.47-0.41-0.15
Net Income
146.87149.69151.84125.38100.7577.48
Net Income to Common
146.87149.69151.84125.38100.7577.48
Net Income Growth
-2.35%-1.42%21.11%24.44%30.04%-
Shares Outstanding (Basic)
151151151151151151
Shares Outstanding (Diluted)
151151151151151151
Shares Change (YoY)
0.08%-----
EPS (Basic)
0.970.991.010.830.670.51
EPS (Diluted)
0.970.991.010.830.670.51
EPS Growth
-2.82%-1.80%21.46%24.08%31.17%-
Free Cash Flow
50.0780.256.1930.1134.1419.22
Free Cash Flow Per Share
0.330.530.040.200.230.13
Dividend Per Share
0.1600.1600.1500.125--
Dividend Growth
6.67%6.67%20.00%---
Gross Margin
33.73%33.71%35.22%36.13%34.87%33.55%
Operating Margin
20.38%19.73%19.05%20.46%17.65%15.57%
Profit Margin
15.05%15.64%16.90%15.27%15.53%13.26%
Free Cash Flow Margin
5.13%8.38%0.69%3.67%5.26%3.29%
EBITDA
269.39249217.5211.8150.94124.7
EBITDA Margin
27.61%26.02%24.20%25.79%23.27%21.34%
D&A For EBITDA
70.5360.1646.2943.7936.4433.73
EBIT
198.86188.84171.21168.01114.590.97
EBIT Margin
20.38%19.73%19.05%20.46%17.65%15.57%
Effective Tax Rate
23.18%18.28%18.23%20.49%17.94%18.54%
Updated Feb 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.